 AFP | FDA Adds New Warnings to Dronedarone (Multaq) Label Forbes The analysis reaffirmed the benefits of dronedarone in ATHENA, finding that dronedarone caused a reduction in hospitalizations and was not associated with an increased risk of cardiovascular death, stroke or heart failure. [12-19-2011] The US Food and ... FDA Further Restricts Use of Sanofi's Multaq FDA adds new heart warning to Sanofi's Multaq FDA Adds New Heart Warning To Sanofi's Multaq |
